The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Sanofi SA

NYSE: SNY
Last

(U.S.) $46.15

Today's change0.00 0.00%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $46.15

Today's change0.00 0.00%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

Sanofi SA closed at (U.S.)$46.15.

Over the last five days, shares have lost 0.52% and sit 4.33% above their 52-week low. This security has underperformed the S&P 500 by 25.05% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $46.15
  • High--
  • Low--
  • Bid / Ask(U.S.) $46.14 / (U.S.) $46.19
  • YTD % change-13.95%
  • Volume2,500
  • Average volume (10-day)2,622,157
  • Average volume (1-month)2,302,671
  • Average volume (3-month)2,571,460
  • 52-week range(U.S.) $44.24 to (U.S.) $57.42
  • Beta1.03
  • Trailing P/E24.51×
  • P/E 1 year forward14.47×
  • Forward PEG3.36×
  • Indicated annual dividend(U.S.) $1.91
  • Dividend yield4.14%
  • Trailing EPS(U.S.) $1.88
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.76%

Based on its net profit margin of 12.76%, Sanofi SA is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue8,8688,1467,9258,545
Total other revenue--------
Total revenue8,8688,1467,9258,545
Gross profit6,0045,5385,4095,643
Total cost of revenue2,8642,6082,5162,902
Total operating expense7,0846,9006,4977,217
Selling / general / administrative2,3092,2552,0782,148
Research & development1,1461,1881,1391,246
Depreciation / amortization561624677682
Interest expense (income), net operating--------
Unusual expense (income)15815554989
Other operating expenses, total467033-750
Operating income1,7841,2461,4281,328
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6451,1521,3871,225
Income after tax1,2648021,1131,093
Income tax, total381350274132
Net income1,1907771,0841,056
Total adjustments to net income--------
Net income before extra. items1,1907771,0841,056
Minority interest-31-27-34-39
Equity in affiliates-43252
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1907771,0841,056
Inc. avail. to common incl. extra. items1,1907771,0841,056
Diluted net income1,1907771,0841,056
Dilution adjustment0------
Diluted weighted average shares1,3131,3151,3201,385
Diluted EPS excluding extraordinary itemsvalue per share0.910.590.820.76
Dividends per sharevalue per share0.000.000.001.30
Diluted normalized EPSvalue per share1.070.670.851.40